Effect of morphine on dynorphin B and GABA release in the basal ganglia of rats

Brain Research

Volumn 710, Issue 1-2, 1996, Pages 241-248

  You, Zhi Bing ^a   Herrera Marschitz, Mario ^a   Nylander, Ingrid ^a   Goiny, Michel ^a   Kehr, Jan ^a   Ungerstedt, Urban ^a   Terenius, Lars ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Amino acid; Dopamine; Dynorphin; Microdialysis; Morphine; Naloxone; Rat

Indexed keywords

4 AMINOBUTYRIC ACID; ASPARTIC ACID; DOPAMINE; DYNORPHIN B; GLUTAMIC ACID; MORPHINE; MU OPIATE RECEPTOR; NALOXONE;

ANIMAL EXPERIMENT; ARTICLE; BASAL GANGLION; CONTROLLED STUDY; GABAERGIC SYSTEM; INTRACEREBRAL DRUG ADMINISTRATION; MALE; MICRODIALYSIS; NEOSTRIATUM; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT; REGIONAL PERFUSION; SUBCUTANEOUS DRUG ADMINISTRATION; SUBSTANTIA NIGRA;

EID: 0029925363     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(95)01402-0     Document Type: Article

References (64)

1. Amaric, M. and Koob, G.F., Low doses of methylnaloxonium in the nucleus accumbens antagonize hyperactivity induced by heroin in the rat, Pharmaol. Biochem. Behav., 23 (1985) 411-415.
2. Bechara, A. and Kooy, D.V.D., Opposite motivational effects of endogenous opioids in brain and periphery, Nature, 314 (1985) 533-536.
3. Bunney, B.S. and Aghajanian, G.K., The precise localization of nigral afferents in the rat as determined by a retrograde tracing technique, Brain Res., 117 (1976) 423-435.
4. Chang, K.-J., Cooper, B.R., Hazum, E. and Cuatrecasas, P., Multiple opiate receptors: different regional distribution in the brain and differential binding of opiates and opioid peptides, Mol. Pharmacol., 16 (1979) 91-104.
5. Christensson-Nylander, I., Herrera-Marschitz, M. Staines, W., Hökfelt, T., Terenius, L., Ungerstedt, U., Cuello, C., Oertel, W.H. and Goldstein, M., Striato-nigral dynorphin and substance P pathways in the rat. I. Biochemical and immunohistochemical evidence, Exp. Brain Res., 64 (1986) 169-192.
6. Di Chiara, G., Olianas, M., Del Fiacco, M., Spano, P.F. and Tagliamonte, A., Intranigral kainic acid is evidence that nigral non-dopaminergic neurones control posture, Nature, 268 (1977) 743-745.
7. Di Chiara, G. and Imperato, A., Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats, J. Pharmacol. Exp. Ther., 244 (1988) 1067-1080.
8. Fallon, J.H. and Ciofi, P., Dynorphin-containing neurons. In A. Björklund, T. Hökfelt and M.J. Kuhar (Eds.), Handbook of Chemical Neuroanatomy, Vol 9: Neuropeptides in the CNS, Part II, Elsevier, 1990, pp. 1-130.
9. Fujimoto, J.M., Arts, K.S., Rady, J.J. and Tseng, L.F., Spinal dynorphin A (1-17): possible mediator of antianalgesic action, Neuropharmacology, 29 (1990) 609-617.
10. Fujimoto, J.M. and Holmes, B., Systemic single dose morphine pretreatment desensitizes mice to the spinal antianalgesic action of dynorphin A (1-17), J. Pharmacol. Exp. Ther., 254 (1990) 1-7.
11. Garcia-Munoz, M., Nicolaou, N.M., Tulloch, I.F., Wright, A.K. and Arbuthnott, G.W., Feedback loop or output pathway in striatal-nigral fibres?, Nature, 265 (1977) 363-365.
12. Gerfen, C.R., Staines, W.A., Arbuthnott, G.W. and Fibiger, H.C., Crossed connections of the substantia nigra in the rat, J. Comp. Neurol., 207 (1982) 283-303.
13. Grofova, I., Deniau, J.M. and Kitai, ST., Morphology of the substantia nigra pars reticulata projection neurons intracellularly labelled with HRP, J. Comp. Neurol., 298 (1982) 352-398.
14. Herrera-Marschitz, M. and Ungerstedt, U., Evidence that striatal efferents relate to different dopamine receptors, Brain Res., 323 (1984) 269-278.
15. Herrera-Marschitz, M., Hökfelt, T., Ungerstedt, U., Terenius, L. and Goldstein, M., Effect of intranigral injections of dynorphin, dynorphin fragments and α-neoendorphin on rotational behaviour in rat, Eur. J. Pharmacol., 192 (1984) 213-227.
16. Herrera-Marschitz, M., Christensson-Nylander, I., Sharp, T., Staines, W., Reid, M., Hökfelt, T., Terenius, L. and Ungerstedt, U., Striatonigral dynorphin and substance P pathways in the rat. II. Functional analysis, Exp. Brain Res., 64 (1986) 193-207.
17. Herrera-Marschitz, M., Meana, J.J., O'Connor, W.T., Goiny, M., Reid, M.S. and Ungerstedt, U., Neuronal dependence of extracellular dopamine, acetylcholine, glutamate, aspartate and gamma-aminobutyric acid (GABA) measured simultaneously from rat neostriatum using in vivo microdialysis: reciprocal interactions, Amino Acids, 2 (1992) 157-179.
18. Herrera-Marschitz, M., You Z-B., Goiny, M., Silveira, R., Godukhin, O.V., Chen, Y., Espinoza, S., Pettersson, E., Loidl, C.F., Andersson, K., Nylander, I., Terenius, L. and Ungerstedt, U., On the origin of extracellular glutamate levels monitored in the basal ganglia of the rat by in vivo microdialysis, J. Neurochem., 66 (1996), in press.
19. Hommer, D.W. and Pert, A., The actions of morphine in the rat substantia nigra: An electrophysiological analysis, Peptides, 4 (1983) 603-608.
20. Hong, J.S., Yang, H.Y.T., Racagni, G. and Costa, E., Projections of substance P containing neurons from neostriatum to substantia nigra, Brain Res., 122 (1977) 541-544.
21. Hökfelt, T., Mårtensson, R., Björklund, A., Kleinau, S. and Goldstein, M., Distribution maps of tyrosine-hydroxylase-immunoreactive neurons in the rat brain. In A. Björklund and T. Hökfelt (Eds.), Handbook of Chemical Neuroanatomy. Vol. 2: Classical Transmitters in the CNS, Part, I, Elsevier, 1984, pp. 277-379.
22. Iwamoto, E.T. and Way, E.L., Circling and stereotypy induced by intranigral opiate microinjections, J. Pharmacol. Exp. Ther., 203 (1977) 347-359.
23. Iwamoto, E.T., Locomotor activity and antinociception after putative mu, kappa and sigma opioid receptor agonists in the rat: Influence of dopaminergic agonists and antagonists, J. Pharmacol. Exp. Ther., 217 (1981) 451-460.
24. Jackisch, R., Holz, H. and Hertting, G., No evidence for presynaptic opioid receptors on cholinergic, but presence of kappa-receptors on dopaminergic neurons in the rabbit caudate nucleus: involvement of endogenous opioids, Naunyn-Schmiedeberg's Arch. Pharmacol., 348 (1993) 234-241.
25. Kehr, J., Determination of GABA in microdialysis samples by microbore HPLC and fluorescence detection, Application Notes 19, CMA/Microdialysis AB, Stockholm, 1994, pp. 1-4.
26. Kilpatrick, I.C., Collingridge, G.L. and Starr, M.S., Evidence for the participation of nigrotectal γ-aminobutyrate-containing neurones in striatal and nigral-derived circling in the rat, Neuroscience, 1 (1982) 207-222.
27. Kita, H. and Kitai, S.T., Glutamate decarboxylase immunoreactive neurons in rat neostriatum: their morphological types and populations, Brain Res., 447 (1988) 346-352.
28. Koob, G.F., Drugs of abuse: anatomy, pharmacology and function of reward pathways, Trends Pharmacol., 13 (1992) 177-184.
29. Krebs, M.-O., Gauchy, C., Desban, M. Glowinski, J. and Kemel, M.-L., Role of dynorphin and GABA in the inhibitory regulation of NMDA-induced dopamine release in striosome-and matrix-enriched areas of the rat striatum, J. Neurosci., 14 (1994) 2435-2443.
30. Lord, J., Waterfield, A., Hughes, J. and Kosterlitz, H.W., Endogenous opioid peptides: multiple agonists and receptors, Nature, 267 (1977) 495-499.
31. Magnan, J.N., Paterson, S.J., Tavani, A. and Kosterlitz, H.W., The binding spectrum of narcotic analgesic drugs with different agonist and antagonist properties, Naunyn-Schmiedeberg's Arch. Pharmacol., 319 (1982) 197-205.
32. 1 receptor mRNA distribution in the rat CNS: Comparison to K receptor binding and prodynorphin mRNA, Mol. Cell. Neurosci., 5 (1994) 124-144.
33. Mansour, A., Fox, C.A., Thompson, R.C., Akil, H. and Watson, S.J., μ;-opioid receptor mRNA expression in the rat CNS: Comparison to μ-receptor binding, Brain Res., 643 (1994) 245-265.
34. Mansour, A. Fox, C.A., Akil, H. and Watson, S.J., Opioid-receptor mRNA expression in the rat CNS: Anatomical and functional implications, Trends Neurosci., 18 (1995) 22-29.
35. Marshall, J.F. and Ungerstedt, U., Striatal efferent fibres play a role in maintaining rotational behaviour in the rat, Science, 198 (1977) 62-64.
36. Martin, W.R., Eades, C.G., Thompson, J.A., Huppler, R.E. and Gilbert, P.E., The effects of morphine-and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog, J. Pharmacol. Exp. Ther., 197 (1976) 196-203.
37. Martin, W.R., Pharmacology of opioids, Pharmacol. Rev., 35 (1984) 283-323.
38. McGeer, P.L., McGeer, E.G., Scherer, U. and Singh, K., A glutamatergic cortico-striatal path?, Brain Res., 128 (1977) 369-373.
39. Morelli, M. and Di Chiara, G., Non-dopaminergic mechanisms in the turning behaviour evoked by intranigral opiates, Brain Res., 341 (1985) 350-359.
40. Mucha, A.H. and Herz, A., Motivational properties of K-and μ-receptor agonists studied with place and taste preference conditioning, Psychopharmacology, 86 (1985) 274-280.
41. Mulder, A.H., Wardeh, G., Hogenboom, F. and Frankhuyzen, A.L., K-and δ-opioid receptor agonists differentially inhibit striatal dopamine and acetylcholine release, Nature, 308 (1984) 278-280.
42. Naito, A. and Kita, H., The cortico-nigral projection in the rat: an anterograde tracing study with biotinylated dextran amine, Brain Res., 637 (1994) 317-322.
43. Nestler, E.J., Molecular mechanisms of drug addiction, J. Neurosci., 12 (1992) 2439-2450.
44. Paxinos, G. and Watson, C., The Rat Brain in Stereotaxic Coordinates, Academic Press, New York, 1982.
45. Pickens, R., Meisch, R.A. and Thompson, T., Drug self-administration: An analysis of the reinforcing effects of drugs, Psychopharmacology, 12 (1978) 1-37.
46. Reid, M., Herrera-Marschitz, M., Hökfelt, T., Terenius, L. and Ungerstedt, U., Differential modulation of striatal dopamine release by intranigral injection of γ-aminobutyric acid (GABA), dynorphin A and substance P, Eur. J. Pharmacol., 147 (1988) 411-420.
47. Reiner, A. and Anderson, K.D., The patterns of neurotransmitter and neuropeptide co-occurrence among striatal projection neurons: conclusions based on recent findings, Brain Res. Rev., 15 (1990) 251-265.
48. Reisine, T. and Bell, G.I., Molecular biology of opioid receptors, Trends Neurosci., 16 (1993) 506-510.
49. Reubi, J. and Cuenod, M., Glutamate release in vitro from cortico-striatal terminals, Brain Res., 176 (1979) 185-188.
50. Schmauss, C. and Herz, A., Intrathecally administered dynorphin-(1-17) modulates morphine-induced antinociception differently in morphine-naive and morphine-tolerant rats, Eur. J. Pharmacol., 135 (1987) 429-431
51. Sharif, N.A. and Hughes, J., Discrete mapping of brain mu and delta opioid receptors using selective peptides: Quantitative autoradiography, species differences and comparison with kappa receptors, Peptides, 10 (1989) 499-522.
52. Simon, E., Opioid receptors and endogenous opioid peptides, Medicinal Res. Rev., 11 (1991) 357-374.
53. Smith, A.D. and Bolam, J.P., The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurons, Trends Neurosci., 13 (1990) 259-265.
54. Tang, A.H. and Collins, R.J., Behaviour effects of a novel kappa opioid analgesic, U-50,488, in rats and rhesus monkeys, Psychopharmacology, 85 (1985) 309-314.
55. Tempel, A. and Zukin, R.S., Neuroanatomical patterns of the μ, δ, and K opioid receptors of the rat brain as determined by quantitative in vitro autoradiography, Proc. Natl. Acad. Sci. USA, 84 (1987) 4308-4312.
56. Terenius, L., A rapid assay affinity for the narcotic receptor in the brain: application to methadone analogues, Acta Pharmacol. Toxicol., 34 (1974) 88-91.
57. Tulunay, F.C., Jen, M.-F., Chang, J.-K., Loh, H.H. and Lee, N., Possible regulatory role of dynorphin on morphine-and β-endorphin-induced analgesia, J. Pharmacol. Exp. Ther., 219 (1981) 296-298.
58. Ungerstedt, U., Herrera-Marschitz, M., Jungnelius, U., Ståhle, L., Tossman, U. and Zetterström, T., Dopamine synaptic mechanisms reflected in studies combining behavioural recordings and brain dialysis, Adv. Biosci., 37 (1982) 219-231.
59. Vaccarino, F.J., Amalric, M., Swerdlow, N.R. and Koob, G.F., Blockade of amphetamine but not opiate induced locomotion following antagonism of dopamine function in the rat, Pharmacol. Biochem. Behav., 24 (1985) 61-65.
60. Vasko, M.R. and Domino, E., Tolerance development to the biphasic effects of morphine on locomotor activity and brain acetylcholine in the rat, J. Pharmacol. Exp. Ther., 207 (1978) 848-858.
61. Vincent, S.R., Hökfelt, T., Christensson, I. and Terenius, L., Immunohistochemical evidence for a dynorphin immunoreactive striato-nigral pathway, Eur. J. Pharmacol., 85 (1982) 251-252.
62. Werling, L.L., Frattali, A., Portoghese, P.S., Takemori, A.L. and Cox, B.M., Kappa receptor regulation of dopamine release from striatum and cortex of rats and guinea pigs, J. Pharmacol. Exp. Ther., 246 (1988) 282-286.
63. +-depolarization, lesions and peptidase inhibition, Neuroscience, 63 (1994) 415-425.
64. You, Z.-B., Herrera-Marschitz, M., Brodin, E., Meana, J.J., Morino, P., Hökfelt, T., Silveira, R., Goiny, M. and Ungerstedt, U., On the origin of striatal cholecystokinin release: studies with in vivo microdialysis, J. Neurochem., 62 (1994) 76-85.